The average dispensing fee in the commercial market is currently less than $2, while in comparison, $10.50 is a common dispensing fee in many states’ fee-for-service (FFS) Medicaid programs. If all states adopted a $10.50 dispensing fee on every commercial
At the State of the Union, President Trump laid out a vision for “the most affordable, innovative, and high-quality health care system on Earth.” In attendance were more than a dozen Americans struggling with high insulin costs…
Pharmaceutical Care Management Association (PCMA) members have long advocated for and implemented new programs to achieve a more equitable health care system.
With the United States in a debate on high drug prices, solutions are being sought that will lower the cost to consumers and taxpayers, while increasing access. However, care must be taken at the federal level to not make changes
While home during their August recess, members of Congress are likely to hear from constituents about a wide range of challenges they’re facing. At the top of many constituents’ lists will be complaints about the rising price of prescription drugs
High prescription drug prices have been a volatile political issue in America for many years. Today’s Democratic presidential candidates all have bemoaned what…
While debating important legislative proposals that can impact patients’ health and access to medications, the discussion should rely on solid facts and evidence. Today, we’re highlighting new reputable third-party research and analyses by economists which underscore that legislation focused on
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) issued the following statement on today’s action by the House Energy and Commerce Subcommittee on Health drug pricing transparency legislation: PCMA applauds the Energy and Commerce Subcommittee on Health for advancing legislation promoting
©2024 PCMA. All Rights Reserved.
